Gyre Therapeutics, Inc. ( GYRE) - Key Metrics
GYRE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.34 | $0.04 | $0.05 | $0.04 |
| 2025Q2 | $0.30 | $0 | $0.02 | $0.02 |
| 2025Q1 | $0.26 | $0.03 | $0 | -$0.01 |
GYRE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | 46.04 |
| 2025Q2 | ? | 370.49 |
| 2025Q1 | ? | 61.82 |
GYRE Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.47% | ? |
| 2025Q4 | -0.90% | ? |
| 2025Q3 | 0.60% | ? |
| 2025Q2 | 0.28% | ? |
| 2025Q1 | -0.14% | ? |
GYRE
Price: $5.75
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.08 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 610.1 million